M&T Bank’s VanEck Pharmaceutical ETF PPH Stock Holding History

M&T Bank’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-28,680	Closed	-$2.2M	–	1661
2022 Q2	$2.2M	Buy	+28,680	New	+$2.24M	0.01%	531
2016 Q1	–	Sell	-13,554	Closed	-$885K	–	1787
2015 Q4	$885K	Buy	+13,554	New	+$875K	0.01%	852

Other funds holding PPH

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LJAC

L.J. Altfest & Co New York $935M AUM 27.19% 1-Year Est. Return

M&T Bank's PPH Position: Q3 2022 in Review

M&T Bank sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2022, closing a stake of 28,680 shares — an estimated $2.2M sold.

M&T Bank first reported a position in PPH in Q4 2015 and held it in 2 quarters. The position peaked at $2.2M in Q2 2022. 86 funds tracked by Wall St. Rank hold PPH as of Q3 2022.

M&T Bank reported no remaining VanEck Pharmaceutical ETF position as of Q3 2022 after selling out during the quarter.
M&T Bank sold 28,680 VanEck Pharmaceutical ETF shares in Q3 2022, an estimated $2.2M.
M&T Bank first reported a position in VanEck Pharmaceutical ETF in Q4 2015 and held it in 2 quarters.
M&T Bank's VanEck Pharmaceutical ETF position peaked at $2.2M in Q2 2022.
86 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2022.

Based on M&T Bank's 13F filing for Q3 2022, filed 14 Nov 2022.